Klin Farmakol Farm. 2012;26(1):5-10

The choice of antihypertensive treatment in hospitalised geriatric patients

Agáta Argalášová1, Veronika Drobná1, Lenka Kostková1, Andrej Dukát2, Ján Murín3, Martin Wawruch1
1 Ústav farmakológie a klinickej farmakológie, Lekárska fakulta, Univerzita Komenského, Bratislava
2 II. interná klinika, Lekárska fakulta, Univerzita Komenského, Bratislava
3 I. interná klinika, Lekárska fakulta, Univerzita Komenského, Bratislava

Aim: The aim of the present work was to analyse the use of antihypertensive medications in a sample of hospitalised elderly patients at

the time of hospital discharge in relationship to age and comorbid conditions.

Methods: The sample of the present study consisted of 515 patients aged ≥65 years with documented arterial hypertension at hospital

discharge. The sample was divided according to age into four groups (65-69; 70-74; 75-79; ≥80 years). The use of antihypertensive medications

and the prevalence of comorbid conditions, which influence the choice of antihypertensive treatment, were compared among

the above-mentioned age groups.

Results: Combinations of three and four antihypertensive drugs were most commonly applied in our sample (28.5% and 25.8%, respectively).

No significant difference was found among the evaluated groups in terms of the number of antihypertensive drugs used (p=0.064).

Diuretics, angiotensin-converting enzyme inhibitors and beta blockers were the most frequently administered antihypertensives in our

sample (71.5%, 69.5% and 68.9%, respectively). Dihydropyridine calcium channel blockers and urapidil were less frequently applied in

the group of oldest patients (p<0.001 and p=0.009, respectively). Atrial fibrillation and chronic renal insufficiency were more commonly

present in the oldest patients of the evaluated sample (p=0.001 and p<0.001, respectively).

Conclusions: The spectrum of antihypertensive medications used in our sample corresponds to the recommendations for pharmacologic

treatment of arterial hypertension. Except dihydropyridine calcium channel blockers and urapidil, no preference for any class of

antihypertensive drugs in a certain age group was found.

Keywords: antihypertensive treatment, elderly patients, diuretics, angiotensin-converting enzyme inhibitors, beta blockers, comorbid conditions

Published: April 24, 2012  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Argalášová A, Drobná V, Kostková L, Dukát A, Murín J, Wawruch M. The choice of antihypertensive treatment in hospitalised geriatric patients. Klin Farmakol Farm. 2012;26(1):5-10.
Download citation

References

  1. Christensen K, Doblhammer G, Rau R, Vaupel JW. Ageing populations: the challenges ahead. Lancet 2009; 374: 1196-1208. Go to original source... Go to PubMed...
  2. Fagard RH. Epidemiology of hypertension in the elderly. Am J Geriatr Cardiol 2002; 11: 23-28. Go to original source... Go to PubMed...
  3. Mancia G, De Backer G, Dominiczak A, et al. Guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007; 25: 1105-1187. Go to original source... Go to PubMed...
  4. Kannel WB, Wolf PA, McGee DL, Dawber TR, McNamara P, Castelli WP. Systolic blood pressure, arterial rigidity, and risk of stroke. The Framingham study. JAMA 1981; 245: 1225-1229. Go to original source... Go to PubMed...
  5. Lloyd-Jones D, Adams R, Carnethon M, et al. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 2009; 119: 480-486. Go to original source... Go to PubMed...
  6. Banach M, Aronow WS. Should we have any doubts about hypertension therapy in elderly patients?: ACCF/AHA 2011 expert consensus document on hypertension in the elderly. Pol Arch Med Wewn 2011; 121: 253-258. Go to original source... Go to PubMed...
  7. Medical Research Council Working Party. MRC trial of treatment of hypertension in older adults: principal results. BMJ 1992; 304: 405-412. Go to original source... Go to PubMed...
  8. Dahlöf B, Lindholm LH, Hansson L, Scherstén B, Ekbom T, Wester PO. Morbidity and mortality in the Swedish Trial in Old Patients with Hypertension (STOP-Hypertension). Lancet 1991; 338: 1281-1285. Go to original source... Go to PubMed...
  9. Beckett NS, Peters R, Fletcher AE, et al. HYVET Study Group. Treatment of hypertension in patients 80 years of age or older. N Engl J Med 2008; 358: 1887-1898. Go to original source... Go to PubMed...
  10. Aronow WS, Fleg JL, Pepine CJ, et al. ACCF/AHA 2011 expert consensus document on hypertension in the elderly: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents. Circulation 2011; 123: 2434-2506. Go to original source... Go to PubMed...
  11. Supiano MA, Hogikyan RV, Sidani MA, Galecki AT, Krueger JL. Sympathetic nervous system activity and alphaadrenergic responsiveness in older hypertensive humans. Am J Physiol 1999; 276: 519-528. Go to original source...
  12. Mancia G, Laurent S, Agabiti-Rosei E, et al. Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document. J Hypertens 2009; 27: 2121-2158. Go to original source... Go to PubMed...
  13. Kithas PA. Supiano MA. Practical recommendations for treatment of hypertension in older patients. Vascular Health and Risk Management 2010; 6: 561-569. Go to original source... Go to PubMed...
  14. Fleg JL, Aronow WS, Frishman WH. Cardiovascular drug therapy in the elderly: benefits and challenges. Nat Rev Cardiol 2011; 8: 13-28. Go to original source... Go to PubMed...
  15. Lindholm LH, Carlberg B, Samuelsson O. Should beta blockers remain first choice in the treatment of primary hypertension? A meta-analysis. Lancet 2005; 366: 1545-1553. Go to original source... Go to PubMed...
  16. Kacířová I, Grundmann M. Porucha příjmu potravy u mladého hypertonika a kompenzace hypertenze. Klin Farmakol Farm 2011; 25: 150-152.
  17. Whelton PK, Appel LJ, Espeland MA, et al. Sodium reduction and weight loss in the treatment of hypertension in older persons: a randomized controlled trial of nonpharmacologic interventions in the elderly (TONE). JAMA 1998; 279: 839-846. Go to original source... Go to PubMed...
  18. ICD - 10th International Statistical Classification of Diseases and Related Health Problems. 10th Revision. Geneva: WHO, 1992: 191.
  19. Atkinson J. Age-related medial elastocalcinosis in arteries: Mechanisms, animal models, and physiological consequences. J Appl Physiol 2008; 105: 1643-1651. Go to original source... Go to PubMed...
  20. Akici A, Kalaça S, U?urlu U, Toklu HZ, Oktay S. Antihypertensive drug utilization at health centres in a district of Istanbul. Pharm Sci 2007; 29: 116-121. Go to original source... Go to PubMed...
  21. Poluzzi E, Strahinja P, Vargiu A, et al. Initial treatment of hypertension and adherence to therapy in general practice in Italy. Eur J Clin Pharmacol 2005; 61: 603-609. Go to original source... Go to PubMed...
  22. Wawruch M, Dukat A, Murin J, et al. The effect of selected patient's characteristics on the choice of antihypertensive medication in the elderly in Slovakia. Pharmacoepidemiol Drug Saf 2009; 18: 1199-1205. Go to original source... Go to PubMed...
  23. Widimský J, eds. Hypertenze. 3. vyd. Praha: Triton, 2008: 706.
  24. ADVANCE Collaborative Group. Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial. Lancet 2007; 370: 829-840. Go to original source... Go to PubMed...
  25. Al Khaja KA, Sequeira RP. Pharmacoepidemiology of antihypertensive drugs in primary care setting of Bahrain between 1998 and 2000. Pharmacoepidemiol Drug Saf 2006; 15: 741-748. Go to original source... Go to PubMed...
  26. Kamijima Y, Ooba N, Yagame M, et al. Hypertension management in diabetic patients: prescribing trends from 1999 to 2005 in three Japanese university hospitals. Pharmacoepidemiol Drug Saf 2008; 17: 904-911. Go to original source... Go to PubMed...
  27. Sciarretta S, Palano F, Tocci G, Baldini R, Volpe M. Antihypertensive treatment and development of heart failure in hypertension: a Bayesian network meta-analysis of studies in patients with hypertension and high cardiovascular risk. Arch Intern Med 2011; 171: 384-394. Go to original source... Go to PubMed...
  28. De Backer G, Ambrosioni E, Borch-Johnsen K, et al. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2003; 24: 1601-1610. Go to original source... Go to PubMed...
  29. EURopean trial On reduction of cardiac events with Perindopril in stable coronary Artery disease Investigators. Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 2003; 362: 782-788.
  30. Fauchier L, Zannad N, Clementy N, Pierre B, Cosnay P, Babuty D. Non-antiarrhythmic drug therapy for the prevention of atrial fibrillation? Ann Cardiol Angeiol 2010; 59: 28-32. Go to original source... Go to PubMed...
  31. Al Khaja KA, Sequeira RP, Damanhori AH. Pharmacotherapy and blood pressure control in elderly hypertensives in a primary care setting in Bahrain. Aging Clin Exp Res 2004; 16: 319-325. Go to original source... Go to PubMed...
  32. Kones R. Recent advances in the management of chronic stable angina II. Anti-ischemic therapy, options for refractory angina, risk factor reduction, and revascularization. Vasc Health Risk Manag 2010; 6: 749-774. Go to original source... Go to PubMed...
  33. Nissen SE, Tuzcu EM, Libby P, et al. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA 2004; 292: 2217-2225. Go to original source... Go to PubMed...
  34. Widimský jr. J. Farmakoterapie arteriální hypertenze. In: Marek J, eds. Farmakoterapie vnitřních nemocí. 4. vyd. Praha: Grada Publishing, 2010: 61-87.




Clinical Pharmacology and Pharmacy

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.